Subsidy under-recovery in Q4
Management noted that DAP margins are not adequate due to raw material cost increases; representation to government ongoing, but correction may not happen before April.
Coromandel International · Material risks, their source context, and severity in the latest available quarter.
ConCallIQ research layer
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Management noted that DAP margins are not adequate due to raw material cost increases; representation to government ongoing, but correction may not happen before April.
Sudden spike in sulfur and sulfuric acid prices due to demand from China and Indonesia could impact input costs.
Export volumes in bioproducts were impacted due to delays in order finalization, though expected to recover in Q4.
Analyst raised concern about pricing-led competition in export markets; management acknowledged but highlighted diversification and formulation foray as mitigants.